Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios D Anastasilakis

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 11, 2020
Serum Profile of microRNAs Linked to Bone Metabolism During Sequential Treatment for Postmenopausal OsteoporosisMaria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras, et al.
Metabolism: Clinical and Experimental|January 1, 2023
Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control studyAthanasios D Anastasilakis, Stergios A Polyzos, Nikolaos E Rodopaios, et al.
Metabolism: Clinical and Experimental|May 20, 2017
Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activityAthanasios D Anastasilakis, Stergios A Polyzos, Marina Tsoli, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|December 22, 2017
Periostin and sclerostin levels in juvenile Paget's diseaseStergios A Polyzos, Polyzois Makras, Athanasios D Anastasilakis, et al.
Rheumatology (Oxford, England)|October 29, 2014
Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formationGrigorios T Sakellariou, Athanasios D Anastasilakis, Ilias Bisbinas, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Approach to the Patient: Management of bone fragility in patients with chronic hypoparathyroidismSymeon Tournis, Evanthia Kassi, Andrea Palermo, et al.
Endokrynologia Polska|August 31, 2012
Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acidStergios A Polyzos, Athanasios D Anastasilakis, Panagiotis Anagnostis, et al.
Acta Bio-Medica : Atenei Parmensis|October 27, 2022
Approach to the management of β thalassemia major associated osteoporosis - A long-standing relationship revisitedMaria P Yavropoulou, Athanasios D Anastasilakis, Ploutarchos Tzoulis, et al.
SICOT-J|March 6, 2026
Glucagon-like peptide-1 receptor agonists in orthopaedicsAndreas F Mavrogenis, Pavlos Altsitzioglou, Sotirios Pililis, et al.
European Journal of Endocrinology|March 12, 2017
Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatmentAthanasios D Anastasilakis, Maria P Yavropoulou, Polyzois Makras, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|June 11, 2020
Serum Profile of microRNAs Linked to Bone Metabolism During Sequential Treatment for Postmenopausal OsteoporosisMaria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras, et al.
Metabolism: Clinical and Experimental|January 1, 2023
Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control studyAthanasios D Anastasilakis, Stergios A Polyzos, Nikolaos E Rodopaios, et al.
Metabolism: Clinical and Experimental|May 20, 2017
Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activityAthanasios D Anastasilakis, Stergios A Polyzos, Marina Tsoli, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|December 22, 2017
Periostin and sclerostin levels in juvenile Paget's diseaseStergios A Polyzos, Polyzois Makras, Athanasios D Anastasilakis, et al.
Rheumatology (Oxford, England)|October 29, 2014
Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formationGrigorios T Sakellariou, Athanasios D Anastasilakis, Ilias Bisbinas, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Approach to the Patient: Management of bone fragility in patients with chronic hypoparathyroidismSymeon Tournis, Evanthia Kassi, Andrea Palermo, et al.
Endokrynologia Polska|August 31, 2012
Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acidStergios A Polyzos, Athanasios D Anastasilakis, Panagiotis Anagnostis, et al.
Acta Bio-Medica : Atenei Parmensis|October 27, 2022
Approach to the management of β thalassemia major associated osteoporosis - A long-standing relationship revisitedMaria P Yavropoulou, Athanasios D Anastasilakis, Ploutarchos Tzoulis, et al.
SICOT-J|March 6, 2026
Glucagon-like peptide-1 receptor agonists in orthopaedicsAndreas F Mavrogenis, Pavlos Altsitzioglou, Sotirios Pililis, et al.
European Journal of Endocrinology|March 12, 2017
Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatmentAthanasios D Anastasilakis, Maria P Yavropoulou, Polyzois Makras, et al.
Pageof 16